You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Sampo Q3’22: Towards dual listing on Stockholm
Sampo had, as usual, excellent underwriting results. CFO Knut Alsaker comment’s on the results, economic situation and future dual listing on Stockholm stock exchange.
Sampo -analysis can be found here https://www.inderes.se/companies/Sampo
00:00 Q3
01:26 Underwriting
03:00 Economy
05:14 Mandatum
08:13 Excess capital
10:12 PE
11:23 Distribution
12:13 Stockholm dual listing
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
View all videos